Blog

GSK’s Acquisition of IDRx

Overview of the Deal Acquirer: GlaxoSmithKline (GSK) Target: IDRx, Inc. Total Transaction Size: Up to $1.15 billion Upfront Payment: $1 billion Potential Milestone Payments: $150

Read More »